NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
CHA University
CHA University
Boehringer Ingelheim
Institut Bergonié
CHA University
Erasmus Medical Center
University Hospital, Montpellier
Huashan Hospital
Helse Nord-Trøndelag HF
University Hospital, Ghent